Can a plastic meniscus implant keep knees Pain-Free for years?

NCT ID NCT03953846

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 27, 2026 · Last updated Sep 09, 2026 · Updated 2 times

Summary

This registry study follows people who receive the NUsurface meniscus implant, a device designed to replace a damaged meniscus in the knee. Researchers track pain and knee function over time using standard scores like KOOS and WOMET. The goal is to see how well the implant works and how safe it is in everyday use. Anyone who is new to the implant or already using it can join.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
NUsurface meniscus implant, a medical device placed in the knee to replace a damaged meniscus
What this could lead to
If the implant holds up over time, it could offer a lasting option for people with knee pain and early osteoarthritis who want to delay or avoid a knee replacement.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove the implant works better than other treatments. Long-term safety and effectiveness are still being checked, and some people may not improve.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

36 people

The number who actually took part.

Started

Jun 2019

Finished

Nov 2023

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population eligible for this protocol includes any subject who received or is scheduled to receive the NUsurface® meniscus implant and meets the Registry inclusion criteria

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * New or current treatment with the NUsurface® meniscus implant * Evidence of a personally signed and dated informed consent document indicating that the subject (or a legally acceptable representative) has been informed of all pertinent aspects of the Registry. Exclusion Criteria: * There are no protocol exclusion criteria; all subjects who meet the inclusion criteria are eligible for enrollment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Knee osteoarthritis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AZ Monica vzw

    Deurne, BE-2100, Belgium

  • Klinikum der Universität München

    München, 81377, Germany

  • Maastricht UMC

    Maastricht, 6229HX, Netherlands

  • Shamir Medical Center

    Ẕerifin, 70300, Israel

  • Sporthopaedicum

    Berlin, 10627, Germany

  • University of Brandenburg

    Brandenburg an der Havel, 14770, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.